CVS is said to shut down clinical trial business

Two years after the launch, pharmacy chain operator CVS Health Corporation (NYSE:CVS) is shutting down its clinical trials business to focus on its core business, Endpoint News reported late Sunday, citing a company statement.

CVS to shut down clinical trial business (update) (NYSE:CVS) | Seeking Alpha